drugset / Trial / NCT04511026

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

NCT04511026

Phase 2 Terminated 6 enrolled Stanford University
NaSingle-groupOpen-labelDiagnostic

Summary

The goal of this study is to (i) improve detection of sentinel nodes and (ii) reduce additional surgical dissection that is needed in case a sentinel lymph node cannot be detected.

Timeline

Start
2021-01-20
Primary completion
2021-06-10
Completion
2021-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.5 ml Other
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 0.5 ml Other

Indications